Nedra Tekaya-Hamouda
C3M, 151 Route De St Antoine De Ginestière, B.P. 2 3194
Nice, 06204, France
Nice, 06204, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Addendum: Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq.
Journal: Nature communications
Published: April 17, 2026
Optimised arylbiamidine derivative as potent in vivo antimelanoma agent: Drug-to-target approach reveals nanomolar GSK3β inhibition.
Journal: Bioorganic chemistry
Published: January 10, 2025
Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring Opening.
Journal: ChemMedChem
Published: September 13, 2023
Development and in vivo evaluation of fused benzazole analogs of anti-melanoma agent HA15.
Journal: Future medicinal chemistry
Published: June 07, 2021
Sulfonylguanidine Derivatives as Potential Antimelanoma Agents.
Journal: ChemMedChem
Published: April 07, 2020
E2F1 inhibition mediates cell death of metastatic melanoma.
Journal: Cell death & disease
Published: November 03, 2017
Structure activity relationship and optimization of N-(3-(2-aminothiazol-4-yl)aryl)benzenesulfonamides as anti-cancer compounds against sensitive and resistant cells.
Journal: Bioorganic & medicinal chemistry letters
Published: January 20, 2017
Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq.
Journal: Nature communications
Published: December 22, 2016
A real-time digital bio-imaging system to quantify cellular cytotoxicity as an alternative to the standard chromium-51 release assay.
Journal: Immunology
Published: October 20, 2016
From benchmarking HITS-CLIP peak detection programs to a new method for identification of miRNA-binding sites from Ago2-CLIP data.
Journal: Nucleic acids research
Published: August 22, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026